Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAID: Compound Danshen Dropping Pills in Coronary Microvascular Disease
NCT07885462Phase 4Not yet recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Oct 2026
- Primary completion
- Nov 2028
- Countries
- 1
01
Overview
A Phase 4 trial of Compound Danshen in coronary microvascular disease (CMD), sponsored by Qilu Hospital of Shandong University. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
Compound Danshen
03
Conditions
coronary microvascular disease (CMD)
Beyond the preview
Go deeper on NCT07885462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07885462.